Since the identification of the novel coronavirus SARS-CoV-2 in December 2019, the disease has spread to nearly every country and territory on the planet, and local governments and authorities have all implemented some form of infection containment measures, whether through travel restrictions, cancellations of large events, business closures, or social isolation, in a bid to slow down and control the pace of infection.

In addition to the unprecedented impact this has had on various aspects of daily life, these measures have also deeply affected various markets, especially those for medical devices. The impact of the COVID-19 pandemic on MedTech has been observed most prominently in markets where procedures are elective, semi-elective, or nonessential, particularly the Dental, Aesthetics, Orthopedics, Urology, and Endoscopy & Open Surgery therapy areas.

In this e-book, we:

  • Identify the COVID-19-related factors limiting procedure volumes,
  • Provide a comparison of impact across therapy areas,
  • Highlight the extent to which specific procedures are impacted,
  • Shed light on the impact on and responses of industry players, and
  • Outline current recovery expectations for various markets.

4 Ways Medtech Supply Chains Have Changed due to COVID-19

View Now